Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications.

Area of Science:

• Neurobiology
• Psychiatry
• Cellular Biology

Background:

• Bipolar disorder (BD) is a chronic mood disorder with complex neurobiological underpinnings.
• Mitochondrial dysfunction is increasingly recognized as a potential contributor to BD pathophysiology.
• Mitochondria are crucial for neuronal energy metabolism and cell survival/death pathways.

Purpose of the Study:

• To review the genetic and physiological aspects of mitochondria in the context of bipolar disorder.
• To examine the evidence supporting mitochondrial abnormalities in BD.
• To explore mitochondria as a potential therapeutic target for bipolar disorder.

Main Methods:

• Literature review synthesizing evidence on mitochondrial function in BD.
• Analysis of genetic and physiological data related to mitochondrial abnormalities.
• Discussion of therapeutic strategies targeting mitochondrial pathways.

Main Results:

• Evidence indicates decreased mitochondrial respiration, altered high-energy phosphates and pH, and changes in mitochondrial morphology in BD.
• Increased mitochondrial DNA polymorphisms and altered expression of nuclear genes involved in mitochondrial respiration are observed in BD.
• These findings highlight significant mitochondrial dysfunction in bipolar disorder.

Conclusions:

• Mitochondrial dysfunction is a key feature in the neurobiology of bipolar disorder.
• Understanding these abnormalities provides insight into BD pathogenesis.
• Targeting mitochondrial pathways represents a promising avenue for novel therapeutic interventions in BD.